PRTA Prothena Plc

Prothena Corp PLC is a biotechnology company. It discovers and develops novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion.

$51.98  +0.64 (1.25%)
As of 07/23/2021 15:59:57 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Ireland
IPO date:  12/21/2012
Outstanding shares:  44,175,792
Average volume:  541,506
Market cap:   $2,267,985,161
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    G72800108
ISIN:        IE00B91XRN20
Sedol:      B91XRN2
Valuation   (See tab for details)
PE ratio:   -18.46
PB ratio:   9.78
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy